CME Group (NASDAQ:CME) reported Q2 EPS of $1.97, $0.04 better than the analyst estimate of $1.93. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.24 billion.
CME Group (NASDAQ:CME) reported Q2 EPS of $1.97, $0.04 better than the analyst estimate of $1.93. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.24 billion.